Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
Public ClinicalTrials.gov record NCT00838591. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Study identification
- NCT ID
- NCT00838591
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- MediciNova
- Industry
- Enrollment
- 176 participants
Conditions and interventions
Conditions
Interventions
- MN-221 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2009
- Primary completion
- Feb 29, 2012
- Completion
- Feb 29, 2012
- Last update posted
- Sep 4, 2013
2009 – 2012
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Loma Linda University Medical Center | Loma Linda | California | 92354 | — |
| UCSD Medical Center - Thornton Hospital | San Diego | California | 92037 | — |
| UCSD Medical Center | San Diego | California | 92103 | — |
| Olive View - UCLA Medical Center | Sylmar | California | 91342 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| Newton - Wellesley Hospital | Newton | Massachusetts | 02462 | — |
| Baystate Medical Center | Springfield | Massachusetts | 01199 | — |
| Hennepin County Medical Center | Minneapolis | Minnesota | 55415 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267-0563 | — |
| Albert Einstein Healthcare Network | Philadelphia | Pennsylvania | 19141 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Sentara General Hospital | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00838591, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2013 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00838591 live on ClinicalTrials.gov.